phase readout
saveNCT06973720: A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Metsera, a wholly owned subsidiary of Pfizer. Phase: PHASE2. Conditions: Obesity, Overweight or Obesity
view source ↗
comments(0)
5-min edit window · permanent after that